Personalization of Medical Treatment Decisions: Simplifying Complex Models while Maintaining Patient Health Outcomes

Christopher Weyant and Margaret L. Brandeau
Additional contact information
Christopher Weyant: Department of Management Science and Engineering, Stanford University, Stanford, CA, USA
Margaret L. Brandeau: Department of Management Science and Engineering, Stanford University, Stanford, CA, USA

Medical Decision Making, 2022, vol. 42, issue 4, 450-460

Abstract: Background Personalizing medical treatments based on patient-specific risks and preferences can improve patient health. However, models to support personalized treatment decisions are often complex and difficult to interpret, limiting their clinical application. Methods We present a new method, using machine learning to create meta-models, for simplifying complex models for personalizing medical treatment decisions. We consider simple interpretable models, interpretable ensemble models, and noninterpretable ensemble models. We use variable selection with a penalty for patient-specific risks and/or preferences that are difficult, risky, or costly to obtain. We interpret the meta-models to the extent permitted by their model architectures. We illustrate our method by applying it to simplify a previously developed model for personalized selection of antipsychotic drugs for patients with schizophrenia. Results The best simplified interpretable, interpretable ensemble, and noninterpretable ensemble models contained at most half the number of patient-specific risks and preferences compared with the original model. The simplified models achieved 60.5% (95% credible interval [crI]: 55.2–65.4), 60.8% (95% crI: 55.5–65.7), and 83.8% (95% crI: 80.8–86.6), respectively, of the net health benefit of the original model (quality-adjusted life-years gained). Important variables in all models were similar and made intuitive sense. Computation time for the meta-models was orders of magnitude less than for the original model. Limitations The simplified models share the limitations of the original model (e.g., potential biases). Conclusions Our meta-modeling method is disease- and model- agnostic and can be used to simplify complex models for personalization, allowing for variable selection in addition to improved model interpretability and computational performance. Simplified models may be more likely to be adopted in clinical settings and can help improve equity in patient outcomes.

Keywords: meta-model; medical decision making; personalized medicine; schizophrenia (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X211037921 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:42:y:2022:i:4:p:450-460

DOI: 10.1177/0272989X211037921

Access Statistics for this article

More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().